The startup scene in France

The University of Montpellier identifies commercialization agreements including co-ownership, licensing, and rights transfer. It describes SATT AxLR as its technology-transfer subsidiary, with an investment fund and access to managed university intellectual property for research teams pursuing commercialization.

The University of Montpellier reported that its 2022 patent filing position placed it among France’s top 50 patent applicants and top 10 higher education institutions by patent count, citing INPI. Medincell attributes its initial long-acting injectable platform to work from a CNRS laboratory led by Michel Vert in Montpellier during 2003–2013. The company reports that the FDA approved UZEDY, its first BEPO-based product, in 2023, and that Teva launched it commercially in the United States.

MedVallée frames its Montpellier-area initiative around health, food and agriculture, and environment. SATT AxLR presents itself as a research-commercialization intermediary and lists the Montpellier Innovation Booster in Montpellier for October 20–22, 2026.

Montpellier BIC describes a six-month Montpellier Game Lab support track for young video game studios and provides an online application route; current intake status was not stated on the inspected page.